Simplex Trading’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,430
Closed -$1.51M 9646
2024
Q1
$1.47M Buy
+7,430
New +$1.36M ﹤0.01% 2715
2023
Q3
Sell
-4,572
Closed -$827K 9644
2023
Q2
$998K Buy
+4,572
New +$1.02M ﹤0.01% 2599
2023
Q1
Sell
-2,953
Closed -$641K 9961
2022
Q4
$614K Buy
+2,953
New +$649K ﹤0.01% 2958
2022
Q2
Sell
-1,186
Closed -$252K 10910
2022
Q1
$287K Sell
1,186
-6,608
-85% -$1.6M ﹤0.01% 4612
2021
Q4
$2.03M Buy
+7,794
New +$2.02M ﹤0.01% 2036
2021
Q3
Sell
-330
Closed -$90.2K 9871
2021
Q2
$81K Buy
+330
New +$69.4K ﹤0.01% 7035
2018
Q3
Sell
-12,911
Closed -$1.41M 7952
2018
Q2
$1.34M Buy
12,911
+8,515
+194% +$862K 0.01% 1515
2018
Q1
$432K Buy
+4,396
New +$415K 0.02% 788
2017
Q3
Sell
-7,608
Closed -$582K 6519
2017
Q2
$592K Sell
7,608
-1,112
-13% -$79.6K 0.03% 567
2017
Q1
$627K Buy
+8,720
New +$603K 0.03% 564
2016
Q4
Sell
-2,510
Closed -$154K 6414
2016
Q3
$162K Buy
2,510
+2,121
+545% +$141K 0.01% 1177
2016
Q2
$24K Sell
389
-762
-66% -$44.9K ﹤0.01% 2739
2016
Q1
$66K Buy
+1,151
New +$65.1K 0.01% 1716
2015
Q3
Sell
-21,995
Closed -$1.18M 6082
2015
Q2
$1.24M Buy
+21,995
New +$1.39M 0.1% 172
2015
Q1
Sell
-709
Closed -$46.1K 5481
2014
Q4
$40K Buy
+709
New +$37K ﹤0.01% 1526

Other funds holding RMD

Simplex Trading's RMD Position: Q2 2024 in Review

Simplex Trading sold out of ResMed (RMD) in Q2 2024, closing a stake of 7,430 shares — an estimated $1.51M sold.

Simplex Trading first reported a position in RMD in Q4 2014 and held it in 15 quarters. The position peaked at $2.03M in Q4 2021. 772 funds tracked by Wall St. Rank hold RMD as of Q2 2024.

  • Simplex Trading reported no remaining ResMed position as of Q2 2024 after selling out during the quarter.
  • Simplex Trading sold 7,430 ResMed shares in Q2 2024, an estimated $1.51M.
  • Simplex Trading first reported a position in ResMed in Q4 2014 and held it in 15 quarters.
  • Simplex Trading's ResMed position peaked at $2.03M in Q4 2021.
  • 772 funds tracked by Wall St. Rank held ResMed as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.